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Abstract 28 
Although virtually all gene networks are predicted to be controlled by miRNAs, the contribution 29 
of this important layer of gene regulation to tissue homeostasis in adult animals remains 30 
unclear. Gain and loss of function experiments have provided key insights into the specific 31 
function of individual miRNAs, but effective genetic tools to study the functional consequences 32 
of global inhibition of miRNA activity in vivo are lacking. Here we report the generation and 33 
characterization of a genetically engineered mouse strain in which miRNA-mediated gene 34 
repression can be reversibly inhibited without affecting miRNA biogenesis or abundance. We 35 
demonstrate the usefulness of this strategy by investigating the consequences of acute 36 
inhibition of miRNA function in adult animals. We find that different tissues and organs respond 37 
differently to global loss of miRNA function. While miRNA-mediated gene repression is 38 
essential for the homeostasis of the heart and the skeletal muscle, it is largely dispensable in 39 
the majority of other organs. Even in tissues where it is not required for homeostasis, such as 40 
the intestine and hematopoietic system, miRNA activity can become essential during 41 
regeneration following acute injury. These data support a model where many metazoan tissues 42 
primarily rely on miRNA function to respond to potentially pathogenic events. 43 
 44 
Introduction 45 
MicroRNAs (miRNAs) are short non-coding RNAs that in Metazoa repress gene expression at 46 
the post-transcriptional level by binding to partially complementary sequences on target 47 
mRNAs (Bartel, 2009, 2018; Eichhorn et al., 2014; Izaurralde, 2015).   48 
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MiRNAs act as part of a large ribonucleoprotein complex known as the miRNA-Induced 49 
Silencing Complex (miRISC). In mammals, the Argonaute protein family (AGO1-4) and the 50 
Trinucleotide Repeat-Containing gene 6 protein family (TNRC6A/GW182, TNRC6B and 51 
TNRC6C) are the core components of the miRISC. AGO binds to the miRNA, and facilitates its 52 
interaction with target mRNAs (Schirle et al., 2014). In turn, TNRC6 binds to AGO and recruits 53 
the decapping and deadenlyation complexes, leading to degradation of target mRNAs (Braun 54 
et al., 2011; Chekulaeva et al., 2011; Chen et al., 2009; Chen et al., 2014; Fabian et al., 2011; 55 
Guo et al., 2010a; Huntzinger et al., 2013; Lazzaretti et al., 2009; Nishihara et al., 2013; 56 
Rehwinkel et al., 2005; Till et al., 2007). 57 
Although miRNAs are abundantly expressed in embryonic and adult mouse tissues, and 58 
computational and experimental analyses indicate that they target components of virtually 59 
every cellular process (Flynt and Lai, 2008), animals harboring targeted deletion of single 60 
miRNA genes are often indistinguishable from their wild type counterparts (Abdellatif, 2012; 61 
Chivukula et al., 2014; Cimmino et al., 2005; Liu et al., 2008; Park et al., 2010; van Rooij et al., 62 
2007; Vechetti et al., 2019; Williams et al., 2009). One explanation for these observations is 63 
that the redundant functions of related miRNAs may buffer the emergence of obvious 64 
phenotypes in mutant animals (Bartel, 2009, 2018). Interestingly, however, clear phenotypes 65 
often emerge in mutant adult animals when exposed to external or internal perturbations 66 
(Chivukula et al., 2014; Mendell and Olson, 2012; van Rooij et al., 2007). These observations 67 
suggest that, at least in some contexts, miRNA function is conditionally, rather than 68 
constitutively, required to carry on cellular processes. 69 
Previous efforts to investigate the consequences of global inhibition of miRNA function have 70 
relied upon the targeted deletion of the core miRNA biogenesis factors DICER, DROSHA, and 71 
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DGCR8 (Treiber et al., 2019). Several animal models harboring conditional or constitutive 72 
knockout alleles of these genes have been generated (Bernstein et al., 2003; Chong et al., 73 
2008; Hebert et al., 2010; Huang et al., 2012; JnBaptiste et al., 2017; Kanellopoulou et al., 74 
2005; Kobayashi et al., 2015; Kumar et al., 2007; Wang et al., 2007). Although these strategies 75 
have provided important insights into miRNA biology, they suffer from several limitations. 76 
First, inactivation of these gene products is known to have other consequences in addition to 77 
impairing miRNA biogenesis. For instance, DICER is involved in epigenetic regulation in the 78 
nucleus in a miRNA-independent manner (Fukagawa et al., 2004; Giles et al., 2010; Gullerova 79 
and Proudfoot, 2012; Okamura and Lai, 2008; Song and Rossi, 2017; Tam et al., 2008), and is 80 
essential to metabolize transcripts from short interspersed nuclear elements, predominantly 81 
Alu RNAs in humans and B1 and B2 RNAs in rodents (Kaneko et al., 2011). DROSHA, on the 82 
other hand, regulates the expression of several coding and non-coding RNAs by directly 83 
cleaving stem–loop structures embedded within the transcripts (Chong et al., 2010). 84 
Furthermore, DICER and DROSHA are also involved in the DNA-damage response (Francia et 85 
al., 2012) (Michelini et al., 2017), and DGCR8 regulates the maturation of small nucleolar 86 
RNAs and of some long non-coding RNAs (Cirera-Salinas et al., 2017; Macias et al., 2015). 87 
Consequently, the phenotypes observed in these models cannot be solely attributed to 88 
inhibition of miRNA activity. 89 
Another limitation of conditional ablation of miRNA-biogenesis genes in vivo is that due to their 90 
high stability mature miRNAs can persist for several days after their biogenesis is inhibited. For 91 
example, four weeks after near complete conditional ablation of Dicer1 in the muscle, the 92 
levels of the highest expressed miRNAs were found to be only reduced by 30-40% and their 93 
expression remained substantial even 18 months later (Vechetti et al., 2019). This complicates 94 
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the interpretation of experiments based on temporally controlled conditional ablation of these 95 
biogenesis factors, especially in non-proliferating tissues. 96 
Third, a subset of mammalian miRNAs does not rely on the canonical biosynthesis pathway, 97 
and therefore their expression and activity are not affected by inactivation of the core miRNA 98 
biogenesis factors (Cheloufi et al., 2010; Chong et al., 2010; Cifuentes et al., 2010; Kim et al., 99 
2016; Okamura et al., 2007; Ruby et al., 2007; Yang and Lai, 2011).   100 
Finally, these genetic approaches are not reversible and therefore these animal models cannot 101 
be used to study the effects of transient inhibition of miRNA function. 102 
To circumvent these limitations, we have generated a novel genetically engineered mouse 103 
strain that allows inducible and reversible disassembly of the miRISC, thereby achieving 104 
controllable inhibition of miRNA-mediated gene repression in vivo without affecting small RNA 105 
biogenesis. To address the reliance of adult tissues on miRNA-mediated gene repression, we 106 
have used this novel strain to investigate the consequences of acute inhibition of the miRISC 107 
under homeostatic conditions, and during tissue regeneration. 108 
 109 
Results  110 
Inhibition of the miRNA pathway through peptide-mediated disruption of the miRISC.  111 
Multiple motifs within the N-terminal domain of TNRC6 proteins contain regularly spaced 112 
tryptophan residues which mediate the interaction between AGO and TNRC6 by inserting into 113 
conserved hydrophobic pockets located on AGO’s Piwi domain (Lian et al., 2009; Sheu-114 
Gruttadauria and MacRae, 2018). 115 
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A peptide encompassing one of the AGO-interacting motifs of human TNRC6B has been 116 
previously employed as an alternative to antibody-based approaches to efficiently pull down all 117 
AGO family members from cell and tissue extracts (Hauptmann et al., 2015; Pfaff et al., 2013). 118 
This peptide, named T6B, competes with endogenous TNRC6 proteins for binding to AGOs. 119 
However, as it lacks the domains necessary for the recruitment of de-capping and de-120 
adenylation factors, it prevents the assembly of the full miRISC, thus resulting in effective 121 
inhibition of miRISC-mediated gene repression in cells (Danner et al., 2017; Hauptmann et al., 122 
2015).   123 
Based on these results, we reasoned that temporally and spatially controlled expression of a 124 
T6B transgene in animals would offer the unprecedented opportunity to study the 125 
consequences of acute and reversible inhibition of miRNA function in vivo without interfering 126 
with miRNA biogenesis or abundance (Figure 1A). 127 
To test the suitability of this approach, we first investigated the dynamics of interaction 128 
between T6B and the miRISC in mouse and human cell lines. We employed a previously 129 
reported size exclusion chromatography (SEC)-based assay (La Rocca et al., 2015; Olejniczak 130 
et al., 2013)  to analyze the molecular weight of AGO-containing complexes in lysates from 131 
cells expressing either a doxycycline-inducible FLAG-HA-T6B-YFP fusion protein (hereafter 132 
referred to as T6B), or a mutant version (hereafter referred to as T6BMut) incapable of binding 133 
to AGO (Figure 1-figure supplement 1). We reasoned that if T6B expression prevents AGO 134 
from stably binding to TNRC6 and its targets, AGO proteins should be detected in fractions 135 
corresponding to approximately 120-130 kDa, the sum of the molecular weights of AGO 136 
(approximately 95 kDa) and the T6B fusion protein (approximately 30 kDa). In contrast, 137 
unperturbed AGO complexes that are part of the fully assembled miRISC bound to mRNAs 138 
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should elute in the void of the column, which contains complexes larger than 2 MDa (Figure 139 
1B).  140 
As expected, in lysates from cells expressing no T6B or T6BMut AGO2 and TNRC6A were 141 
mostly detected in the high molecular weight fractions, indicating the presence of target-bound 142 
miRISC (Figure 1C). In contrast, AGO2 and TNRC6A were nearly completely depleted from 143 
the high molecular weight fractions in lysates from cells expressing T6B (Figure 1C). 144 
Moreover, while AGO2, TNRC6A and the polyA-binding protein 1 (PABP1) co-fractionated in 145 
lysates from control cells, they eluted in different fractions in lysates from T6B-expressing cells 146 
(Figure 1C), indicating that T6B leads to loss of interactions between the miRISC components 147 
and mRNAs. As expected based on the strong evolutionary conservation of human and mouse 148 
AGO and TNRC6 proteins (Pfaff et al., 2013; Zielezinski and Karlowski, 2015; Zipprich et al., 149 
2009), we obtained identical results when human T6B was expressed in mouse embryo 150 
fibroblasts (MEFs) (Figure 1-figure supplement 2). 151 
To test whether the redistribution of AGO-containing complexes induced by T6B expression 152 
was mirrored by a loss of miRNA-mediated gene repression, we performed RNAseq analysis 153 
on MEFs expressing T6B or T6BMut. Cells expressing T6B displayed marked and selective de-154 
repression of predicted mRNA targets for expressed miRNAs (Figure 1D). The extent of de-155 
repression was roughly proportional to the abundance of individual miRNA families, with 156 
predicted targets of poorly expressed miRNAs collectively showing modest de-repression 157 
compared to targets of more abundantly expressed miRNA families (Figure 1D). Importantly, 158 
de-repression of miRNA targets was not accompanied by a global change in mature miRNAs 159 
levels (Figure 1E), consistent with the role of T6B in perturbing the effector step of the miRNA 160 
pathway, without affecting miRNA processing.  161 
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Of the four mammalian AGO proteins, AGO2 is the only one that has endo-ribonucleolytic 162 
activity, which does not require TNRC6 (Liu et al., 2019) and is triggered when the AGO2-163 
loaded small RNA and the target are perfectly complementary (Doench et al., 2003; Liu et al., 164 
2004; Zeng et al., 2003). AGO2’s catalytic activity is essential for gene regulation in the 165 
germline. For example, in mouse oocytes, AGO2 loaded with endogenous small-interfering 166 
RNAs (endo-siRNAs) mediates the cleavage of coding and non-coding transcripts bearing 167 
perfectly complementary sequences (Stein et al., 2015; Tam et al., 2008). In metazoan 168 
somatic tissues, in contrast, AGO2 catalytic activity is mainly involved in the biogenesis of miR-169 
486 and miR-451 in the hematopoietic system (Cheloufi et al., 2010; Jee et al., 2018), and in 170 
occasional instances of miRNA-directed cleavage of mRNAs (Yekta et al., 2004). 171 
Importantly, T6B expression does not interfere with the ability of synthetic siRNAs to cleave 172 
perfectly complementary endogenous targets (Figure 1F), indicating that AGO2’s catalytic 173 
function is not affected by the binding of T6B, and implying that the loading of small RNAs onto 174 
AGOs is also not perturbed by T6B. 175 
Collectively these results demonstrate that ectopic T6B expression in mammalian cells causes 176 
global inhibition of miRISC function with minimal perturbation of the expression of mature 177 
miRNAs, and with preservation of AGO2’s endo-nucleolytic activity. 178 
 179 
Generation of a mouse strain with inducible expression of a T6B transgene.  180 
To apply this general strategy to an in vivo setting, we next generated mouse embryonic stem 181 
cells (mESCs) expressing a doxycycline-inducible T6B transgene. We used a knock-in 182 
approach in which the doxycycline-inducible transgene is inserted into the Col1a1 locus of 183 
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mESC expressing the reverse tetracycline-controlled transactivator (rtTA) under the control of 184 
the endogenous Rosa26 promoter (Beard et al., 2006) (Figure 2A). Targeted mESCs were 185 
tested for the ability to express the T6B transgene in response to doxycycline (Figure 2-figure 186 
supplement 1) and then used to generate mice with genotype Rosa26rtTA/rtTA; Col1a1T6B/T6B 187 
(hereafter R26T6B). Rosa26rtTA/rtTA; Col1a1+/+ mice, with untargeted Col1a1 loci but expressing 188 
rtTA served as negative controls (hereafter R26CTL). 189 
Upon doxycycline administration we observed strong expression of T6B in R26T6B mice and 190 
across most adult tissues (Figure 2B). Notable exceptions were the central nervous system 191 
(Figure 2B, Figure 2-figure supplement 2), probably due to low blood-brain barrier 192 
penetration of doxycycline, and the skeletal muscle and the heart, most likely due to low 193 
expression of the rtTA transgene in these tissues (Premsrirut et al., 2011).  194 
When doxycycline was administered in the diet, T6B became detectable after 24h, reached a 195 
plateau after three days, and completely disappeared four days after doxycycline removal from 196 
the diet (Figure 2C). 197 
Because colon and liver expressed uniformly high levels of T6B in response to doxycycline, we 198 
used these tissues to test the effects of T6B expression on miRISC activity in vivo. Co-IP 199 
experiments using antibodies directed to T6B confirmed the interaction between AGO and T6B 200 
in these tissues (Figure 2D, Figure 2-figure supplement 3). Expression of T6B resulted in 201 
nearly complete disassembly of the miRISC, as indicated by the elution shift of AGO from the 202 
high molecular weight to low molecular weight fractions in both tissues (Figure 2E, Figure 2-203 
figure supplement 4). Importantly, doxycycline removal from the diet led to a complete 204 
reconstitution of the miRISC, as indicated by the reappearance of AGO2 in the high molecular 205 
weight fractions (Figure 2E). 206 
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To test whether T6B expression also resulted in inhibition of miRNA-mediated gene repression 207 
in vivo, we performed RNAseq on total RNAs extracted from the liver and colon of R26T6B and 208 
R26CTL mice kept on doxycycline-containing diet for one week. As shown in Figure 2F, T6B 209 
expression resulted in marked de-repression of miRNA targets in both tissues. 210 
Based on these results we conclude that T6B expression allows acute and reversible 211 
disruption of the miRISC, and concomitant inhibition of miRNA function in vivo. 212 
 213 
Consequences of miRISC disruption in adult tissues under homeostatic conditions.  214 
Given the central role of miRNAs in gene regulatory networks, one might expect widespread 215 
phenotypes emerging when miRISC function is systemically inhibited. Consistent with this 216 
hypothesis, inhibition of miRISC starting either at conception (Figure 3A) or at mid-gestation 217 
caused developmental defects and perinatal lethality in R26T6B mice (Figure 3B, Figure 3-218 
figure supplement 1). Histological examination of hematoxylin-eosin-stained sections of P0 219 
R26T6B pups treated with Doxycycline starting at mid-gestation confirmed a general delay in 220 
development and reduced growth, but no specific organ defects. Surprisingly, however, adult 221 
R26T6B mice kept on doxycycline diet for up to two months remained healthy and appeared 222 
normal upon macroscopic and histopathologic examination. 223 
Detailed examination of the intestine confirmed extensive T6B expression in the epithelium 224 
and in the mesenchymal compartment (Figure 3-figure supplement 2), but no architectural 225 
abnormalities were observed (Figure 3C). Cells in the crypts showed no significant changes in 226 
expression pattern of Ki67 protein (Figure 3-figure supplement 3), suggesting that the 227 
proliferation and turnover of the epithelium is maintained even in absence of a functional 228 
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miRISC.  No significant change in the number of goblet cells was detected throughout the 229 
intestine (Figure 3-figure supplement 4), and mice maintained normal body mass throughout 230 
the period of doxycycline treatment (Figure 3-figure supplement 5), suggesting that general 231 
intestinal functions were not affected.  232 
Although no obvious macroscopic, functional, or architectural abnormalities were caused by 233 
T6B expression in the intestine, we observed a reduction in lysozyme expression in Paneth 234 
cells in the crypts (Figure 3D, upper row). However, this phenotype was reversible, as 235 
lysozyme signal in the crypts returned to normal levels when doxycycline was removed from 236 
the diet (Figure 3D, lower row), suggesting that T6B expression did not affect neither the 237 
viability of intestinal stem cells, nor their self-renewal ability.  238 
Complete blood counts showed a modest, but significant, decrease in erythrocytes volume 239 
(MCV) and hemoglobin content (MCH) in R26T6B RBCs (Figure 3E, Figure 3-figure 240 
supplement 6), analogously to what reported in mice harboring targeted deletion of miR-451 241 
(Patrick et al., 2010). Flow cytometric analysis of bone marrow showed a 3-fold depletion in 242 
Pre-B cells as well as a significant decrease in immature and mature circulating B cells in 243 
R26T6B mice. We also observed a reciprocal increase in the frequency of Pro-B cells in the 244 
bone marrow of these animals (Figure 3F, Figure 3-figure supplement 7). These results are 245 
reminiscent of the partial block in B cell differentiation observed upon deletion of the miR-246 
17~92 cluster (Ventura et al., 2008). 247 
Further characterization of hematopoietic stem cells showed that the number of long-term 248 
repopulating hematopoietic stem cells (LT-HSC) was unaffected after 3 weeks of doxycycline 249 
exposure. However, we observed a modest decrease in short-term repopulating HSCs (ST-250 
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HSCs) and a concomitant increase in multipotent progenitors (MPPs) relative to controls 251 
(Figure 3G, Figure 3-figure supplement 8).  252 
Collectively, these data suggest that in a subset of adult tissues miRISC function can be 253 
suppressed with minimal or no consequences on the ability of these tissues to maintain 254 
homeostasis. 255 
 256 
miRISC disruption impairs the regeneration of injured colon epithelium.  257 
Several studies have shown that the phenotype caused by targeted deletion of individual 258 
miRNAs often manifests only after the mutant animals are subjected to “stress” (Chivukula et 259 
al., 2014; Leung and Sharp, 2010; Mendell and Olson, 2012; van Rooij et al., 2007). For 260 
example, ablation of miR-143/145 causes no apparent phenotype under homeostasis but 261 
severely impairs the ability of the mutant animals to respond to acute damage to the intestinal 262 
epithelium (Chivukula et al., 2014).  263 
Prompted by these reports, and by our initial observation that prolonged T6B expression does 264 
not substantially affect intestinal homeostasis, we tested the consequences of miRISC 265 
disruption on the regenerating intestine. A cohort of R26T6B and R26CTL mice were kept on 266 
doxycycline-containing diet for ten days, after which they were treated with dextran sulfate 267 
sodium (DSS), which induces severe colitis in mice (Chivukula et al., 2014; Okayasu et al., 268 
1990). 269 
A significant and progressive loss of body mass was observed in both groups during DSS 270 
treatment and two days following DSS removal (Figure 4A). However, R26T6B mice lost body 271 
mass more rapidly than controls and reached critical health conditions seven days after DSS 272 
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removal. Three days after DSS removal, control animals started to regain weight, reaching the 273 
initial body mass within five days after DSS removal (Figure 4A). In contrast, R26T6B mice 274 
failed to fully recover (Figure 4A), and all reached a humane endpoint within five days after 275 
DSS removal from the diet (Figure 4B).  276 
Histological analysis confirmed that DSS treatment induced the disruption of the architecture of 277 
the epithelium, and the appearance of ulcerative areas to a similar extent in both R26T6B and 278 
R26CTL control mice (Figure 4C, Figure 4-figure supplement 1). In contrast, although five 279 
days after DSS removal the integrity of the colonic epithelium of control mice was largely 280 
reestablished with the exception of isolated dysplastic areas (Figure 4-figure supplement 2), 281 
extensive ulcerated regions persisted in the colon of R26T6B mice (Figure 4C). Importantly, we 282 
observed the presence of dysplastic epithelium in R26T6B mice during and after DSS treatment, 283 
indicating that miRISC disruption does not completely abolish the potential of cells to 284 
proliferate, as also confirmed by Ki67 staining (Figure 4D). Therefore, we speculate that other 285 
factors, such as impaired stem cell maintenance or differentiation, may be responsible for the 286 
increased susceptibility of T6B-expressing colon to DSS treatment.  287 
Chivukula and colleagues have shown that defective intestinal regeneration in the colon of 288 
miR-143/145-deficient mice is associated with upregulation of the miRNA-143 target IGFBP5 289 
in the mesenchymal compartment. The increased levels of IGFBP5 protein cause the inhibition 290 
of IGF1R signaling in the epithelium through a non-cell autonomous mechanism, which 291 
ultimately prevented epithelial regeneration (Chivukula et al., 2014). Consistent with their 292 
findings, in situ hybridization analyses in the colon of DSS-treated R26T6B mice showed a 293 
significant upregulation of IGFBP5 mRNA in the mesenchymal compartment compared to 294 
controls (Figure 4E). The extent of de-repression of IGFBP5 was comparable to that 295 
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previously observed in miRNA-143/145 knockout mice (Chivukula et al., 2014), providing 296 
further evidence that T6B-mediated miRISC disassembly is an effective strategy to globally 297 
inhibit miRNA function in vivo. 298 
Collectively, these results support a model whereby miRNA-mediated gene regulation, while 299 
dispensable to maintain normal colon homeostasis, becomes critical for its regeneration 300 
following acute damage. 301 
 302 
miRISC disruption impairs regeneration of the hematopoietic system.  303 
To further characterize the consequences of miRISC inhibition during tissue regeneration, we 304 
explored the possibility that other tissues may adopt a similar dynamic reliance on miRNA 305 
function. 306 
Along with the intestinal epithelium, blood is one of the most rapidly turned over tissues in 307 
mice. Hematopoietic stem cells (HSCs) reside as a predominantly quiescent population in the 308 
bone marrow and are rapidly induced to re-enter the cell cycle in response to external cues, 309 
such as infection or injury (Ng and Alexander, 2017). Furthermore, HSCs can be readily 310 
isolated by flow cytometry and transplanted, allowing the study of mechanisms underlying 311 
regeneration at the single cell level. 312 
To test the consequences of miRISC disruption in the regenerating hematopoietic system, we 313 
treated R26T6B and R26CTL mice on doxycycline-containing diet with a single dose of the 314 
cytotoxic drug 5-fluorouracil (5FU). 5-FU selectively depletes rapidly proliferating 315 
hematopoietic progenitors and leads to a compensatory increase in LT-HSC proliferation. Flow 316 
cytometry analysis of the bone marrow seven days after 5FU-injection showed that T6B 317 
 15
expression prevented this compensatory increase in LT-HSC. We observed an identical 318 
phenotype when R26T6B and R26CTL mice that were bled repeatedly over a 3-week period to 319 
induce LT-HSC to re-enter the cell cycle (Figure 5A).  320 
The decreased number of HSCs in the bone marrow of R26T6B mice after a single 5-FU 321 
challenge compared to controls, suggested that miRISC disruption impaired HSCs’ ability to 322 
re-enter the cell cycle and regenerate the hematopoietic compartment. Consistent with this 323 
hypothesis, when injected with repetitive 5-FU doses, R26T6B mice showed significantly shorter 324 
survival compared to controls (Figure 5B).  325 
To measure the regenerative capacity of HSCs more directly in a context where T6B would 326 
only be expressed in hematopoietic cells, we performed competitive transplantation of T6B-327 
expressing (CD45.2+) and wild-type (CD45.1+) bone marrows (1:1 ratio) into lethally irradiated 328 
hosts. The recipient animals were divided into four groups as shown in Figure 5C: (i) a control 329 
group that was never administered doxycycline; (ii) a group maintained on a doxycycline-330 
containing diet throughout the duration of the experiment (8 weeks); (iii) a group treated with 331 
doxycycline starting 4 weeks after transplant; and (iv) a group that was on doxycycline for only 332 
the first 4 weeks after transplant. Blood samples were taken at 4 and 8 weeks following the 333 
start of the experiment for analysis (Figure 5C). This experiment was designed to test the 334 
prediction that expression of T6B during the first 4 weeks following transplant, when the 335 
regenerative demand is highest and when we hypothesize miRNA-mediated gene repression 336 
is required, would more severely affect the ability of donor cells to contribute to the recipient 337 
hematopoietic reconstitution compared to T6B expression after homeostasis is reestablished. 338 
Consistent with this prediction, mice that were administered doxycycline in the first 4 weeks 339 
post-transplant had significantly fewer CD45.2+ peripheral blood mononuclear cells (PBMCs) 340 
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(Figure 5D). Contribution to the B cell population was particularly impaired by T6B expression 341 
but this was reversed once the recipients were taken off of doxycycline, consistent with the 342 
developmental block described earlier (Figure 3D, Figure 3-figure supplement 7). 343 
Interestingly, the decrease in total CD45.2+ PBMCs and CD45.2+ myeloid cells was not 344 
reversed by doxycycline withdrawal, which suggested the T6B-expressing CD45.2+ HSCs 345 
might have been outcompeted by wild-type CD45.1+ HSCs in these recipients (Figure 5D). 346 
Consistent with this hypothesis we observed a significant reduction in CD45.2+ HSCs only in 347 
the bone marrow of recipient animals that were fed a doxycycline-containing diet in the first 4 348 
weeks post-transplant (Figure 5E). 349 
Taken together, these results support a model where the miRNA-mediated gene regulation is 350 
conditionally essential for the maintenance of hematopoietic stem cells during acute 351 
regeneration but is largely dispensable under homeostasis. 352 
 353 
An essential role for miRNA-mediated gene repression in the skeletal muscle and in the 354 
heart.  355 
As previously discussed, we observed low or no expression of T6B in the heart and skeletal 356 
muscle of R26T6B mice treated with doxycycline (Figure 2-figure supplement 2), consistent 357 
with previous reports indicating that rtTA expression from the endogenous Rosa26 promoter is 358 
tissue restricted (Premsrirut et al., 2011). To extend the analysis of the phenotype caused by 359 
the loss of miRISC activity to these tissues, we crossed T6B transgenic mice with the Rosa26-360 
CAGs-rtTA3 strain (Dow et al., 2014) in which the modified chicken beta-actin with CMV-IE 361 
enhancer (CAG) promoter (Niwa et al., 1991) drives a more ubiquitous expression of the rtTA 362 
variant rtTA3 (hereafter CAGT6B). As expected, the pattern and intensity of T6B expression 363 
 17
upon dox administration in CAGT6B mice and R26T6B mice were largely overlapping, except for 364 
the heart and the skeletal muscle, for which significant T6B expression was only observed in 365 
CAGT6B mice (Figure 6A, Figure 2-figure supplement 2). RNAseq analyses confirmed 366 
inhibition of miRNA function in both heart and skeletal muscle of CAGT6B mice upon dox 367 
administration (Figure 6B). 368 
In contrast to R26T6B mice, CAGT6B mice fed a doxycycline-containing diet showed a 369 
progressive decline in body mass (Figure 6-figure supplement 1) and died or reached a 370 
humane endpoint within 4-6 weeks (Figure 6C). The decrease in body mass was not caused 371 
by intestinal malabsorption as, similarly to what observed in R26T6B mice, we found no 372 
evidence of architectural defects throughout the intestine. In contrast, histopathologic 373 
examination of heart and skeletal muscle showed severe alterations in both organs, including 374 
dilated cardiomyopathy and diffuse muscular degeneration (Figure 6D). All mice also showed 375 
necro-inflammatory changes in the liver, variable alterations in the pancreas, and increased 376 
urea nitrogen and alanine aminotransferase levels in the serum. Such alterations are likely 377 
secondary to congestive heart failure, and/or to severe muscle catabolism as they were not 378 
observed in R26T6B mice. Another phenotype that distinguished the R26T6B strain from the 379 
CAGT6B strain was the presence in the latter of vasculitis of pulmonary veins (Figure 6-figure 380 
supplement 2). A likely explanation is that these lesions are caused by increased pressure in 381 
the pulmonary veins secondary to congestive heart failure, but we cannot exclude that they 382 
reflect a direct effect of T6B expression on the pulmonary vasculature. Discriminating between 383 
these two possibility will require the use of transgenic mice harboring tissue restricted rtTA 384 
transgenes. 385 
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The emergence of severe cardiac and skeletal muscle phenotypes, as opposed to the lack of 386 
obvious structural and functional abnormalities in most T6B-expressing tissues, points toward 387 
the existence of significant differences among adult tissues in their reliance on the miRNA 388 
pathway during homeostasis. 389 
Discussion 390 
We report the generation of a novel genetically engineered mouse strain in which miRISC 391 
assembly and function can be temporally and spatially controlled in a reversible manner by a 392 
doxycycline-inducible transgene encoding a T6B-YFP fusion protein to address the role(s) 393 
miRNA-mediated gene regulation plays in vivo in adult tissues. 394 
Surprisingly, in most adult tissues, we do not find an essential role for miRNA-mediated gene 395 
repression in organ homeostasis. A notable exception are the heart and the skeletal muscle, 396 
where miRISC inactivation in adult mice results in acute tissue degeneration and death even in 397 
the absence of tissue damage or exogenous stress. 398 
Even though miRISC function is not overtly required for the homeostasis of other tissues, we 399 
have investigated the consequences of miRNA inhibition in the intestine and in the 400 
hematopoietic system of adult mice under homeostatic conditions and during tissue 401 
regeneration. These are tissues that periodically respond to external/internal stresses. In both 402 
tissues we have found that miRISC activity is dispensable for homeostasis. However, miRNA 403 
function becomes essential during tissue regeneration following acute injury. These results 404 
lend experimental support to the hypothesis that a major role for miRNA-mediated gene 405 
repression is to support tissue adaptation to stress.  406 
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In previous studies where Dicer1 was conditionally ablated in the skeletal muscle of adult mice, 407 
muscle regeneration was impaired after acute injury, but no effect on muscle morphology or 408 
function was observed during homeostasis (Oikawa et al.; Oikawa et al.; Vechetti et al.). An 409 
explanation for this difference is that in the Dicer1 conditional knockout experiments miRNA 410 
levels were only partially reduced even weeks after Dicer1 ablation, likely reflecting the high 411 
stability of these short non-coding RNAs. The T6B mouse strain we describe here overcomes 412 
this major limitation and allows the rapid and effective inhibition of miRNA-activity 413 
independently from the half-life of these molecules.  414 
In this manuscript we have focused on the role of miRNA-mediated gene repression in adult 415 
mice. The same strategy for the acute inhibition of miRISC-activity can in principle be applied 416 
to other organisms. We have found that expression of T6B in embryos of both sea urchin 417 
(Paracentrotus lividus) and zebrafish (Danio rerio), induces developmental defects and gene 418 
expression changes consistent with the essential role of the miRNA pathway during 419 
development (Ambros and Horvitz, 1984; Chalfie et al., 1981; Lee et al., 1993; Reinhart et al., 420 
2000; Song et al., 2012; Wienholds et al., 2003; Wightman et al., 1993)  (Figure 6-figure 421 
supplement 3). Considering that in vitro T6B efficiently binds to AGO proteins from different 422 
non-mammalian organisms (Hauptmann et al., 2015), these findings are not unexpected, yet 423 
they highlight the usefulness of the T6B system for dissecting the miRNA pathway in a variety 424 
of animal models. 425 
Despite its many advantages, the T6B mouse strain has also some unique limitations that 426 
need to be considered when designing and interpreting experiments.  427 
First, although our biochemical and computational analysis of cells and tissues expressing T6B 428 
indicate that the peptide can effectively impair miRISC function, we cannot exclude some 429 
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residual miRISC activity even in cells expressing high levels of the T6B transgene. The 430 
observation that we can recapitulate phenotypes observed in mice harboring complete 431 
targeted deletion of miR-143/145 miRNAs in the intestine (Chivukula et al., 2014) and of miR-432 
17~92 and miR-451 in the hematopoietic system (Koralov et al., 2008; Patrick et al., 2010; 433 
Ventura et al., 2008) is reassuring in this respect.  For example, consistent with observations 434 
made in the regenerating intestine of miRNA-143/145 knockout mice (Chivukula et al., 2014), 435 
we did not record any abnormalities or toxicity during the normal intestinal homeostasis of 436 
R26T6B mice, whereas T6B expression became lethal during intestinal regeneration. Moreover, 437 
in the hematopoietic system, abnormalities were mostly restricted to B cell maturation, which 438 
are consistent with a developmental block at the Pro-B to Pre-B transition found in mir17~92 439 
knockout mice (Ventura et al., 2008). Finally, we also observed a statistically significant 440 
decrease in hematocrit, erythrocyte volume and hemoglobin content in adult T6B-expressing 441 
mice, analogous to what reported in mice harboring targeted deletion of miR-451 (Patrick et 442 
al., 2010).  443 
In contrast, some of our results markedly differ from results obtained by conditional ablation of 444 
Dicer1 in mice. For example, conditional knockout of Dicer1 in the hematopoietic system has 445 
been reported to result in the rapid depletion of HSCs (Guo et al., 2010b). Furthermore, the 446 
lack of an overt phenotype in the intestine contrasts with previous reports showing that post-447 
natal, conditional deletion of Dicer1 results in depletion of goblet cells (Biton et al., 2011; 448 
McKenna et al., 2010), in addition to abnormal vacuolation and villous distortion in the small 449 
intestine (Huang et al., 2012; McKenna et al., 2010). We cannot exclude that these differences 450 
are due to an incomplete inactivation of the miRNA pathway in T6B mice, but an alternative 451 
explanation is that they reflect the well-characterized miRNA-independent functions of DICER.  452 
 21
Another limitation to be considered is the possibility that T6B expression impairs the activity of 453 
other complexes in addition to the miRISC. Although RNAseq analysis of cells expressing T6B 454 
has not revealed changes that are not explained by loss of miRNA-mediated gene repression 455 
and the phenotypes observed are consistent with loss of miRNA activity, this possibility cannot 456 
be formally excluded at this time. Further studies to experimentally identify T6B interactors in 457 
cells and tissues will be important to formally address this possibility.  458 
In conclusion, we have developed a novel mouse strain that enables investigating the role of 459 
miRNA-mediated gene repression in adult organisms. The body of data presented here 460 
suggests that in adult animals miRNAs primarily provide for the ability to adaptively change 461 
gene expression in response to the physiologic and pathologic stresses that accompany 462 
metazoans’ life. It is likely that the specific miRNAs and stresses differ based on the adult 463 
organ or tissue being studied and the model we have generated will be useful address these 464 
important aspects of miRNA biology.  465 
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Figure Legends 497 
Figure 1. T6B fusion protein prevents miRISC assembly and impairs miRNA activity in vitro. 498 
(A) Schematics of T6B action: T6B competes with TNRC6 for binding to AGO proteins 499 
preventing miRISC assembly. (B) Schematics of the size exclusion chromatography (SEC) 500 
assay for the fractionation of AGO-containing complexes according to their molecular weight. 501 
(C) SEC profiling of miRISC components upon T6B expression: Total lysates from HCT116 502 
cells expressing no fusion protein (upper panel), T6B (middle panel) or T6BMut (lower panel) 503 
were fractionated as described in (B) and immunoblotted to detect AGO2, TNRC6A, T6B and 504 
PABP1. For each blot the relative signal intensity was assessed by densitometric analysis. (D) 505 
RNAseq analysis of total and small RNAs isolated from MEFs cell lines expressing either no 506 
fusion protein, T6B or T6BMut (n = 3 for each cell line). Upper panel: bubble plot of target de-507 
repression against miRNA abundance. The mean log2Fold Change (T6B or T6BMut vs control) 508 
of predicted targets for each conserved miRNA family was calculated, converted to a z-score 509 
and is plotted on the x-axis against the miRNA family abundance (log of the sum of read 510 
counts for each member of the family).  The size of each circle is proportional to the number of 511 
predicted targets. A positive z score indicates that the targets for that family are preferentially 512 
upregulated upon T6B expression, while a negative score would indicate preferential 513 
downregulation. Expression of T6B, but not of T6BMut, causes preferential upregulation of 514 
miRNA targets of the most miRNA families and the effect is roughly proportional to each 515 
miRNA family abundance. Lower panel: cumulative distribution plot of predicted let-7 targets 516 
compared to background in T6B-expressing MEFs. (E) Scatter plots of miRNA abundance as 517 
determined by small-RNAseq of total RNA extracted from MEFs expressing either T6B or 518 
T6BMut (n = 3 for each cell line).  Each dot represents a miRNA in miRbase. (F) Effect of T6B 519 
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expression on AGO2 slicing activity. MEFs expressing either T6B or T6BMut were transfected 520 
with siRNAs targeting GAPDH mRNA (siGAPDH) or with scramble siRNA (siCTL). Levels of 521 
GAPDH, T6B and tubulin were assessed by immunoblot 72 hours post-transfection. T6B and 522 
T6BMut have slightly different migration on PAGE, as previously observed by Hauptmann at al. 523 
(Hauptmann et al., 2015).  524 
The following figure supplements and source data are available for Figure 1: 525 
Figure 1- figure supplement 1. Binding of T6B with AGO protein in vitro. 526 
Figure 1- figure supplement 2. T6B-mediated disassembly of the miRISC in murine cells. 527 
Figure 1- source data 1. RNAseq, differential gene expression MEFs. 528 
Figure 1 - source data 2. zScores and miRNA family abundance, MEFs. 529 
Figure 1 - source data 3. small RNAseq, microRNA counts, MEFs. 530 
Figure 1 - source data 4. Unedited blots shown in Figure 1C. 531 
Figure 1 - source data 5. Uncropped blots shown in Figure 1C. 532 
Figure 1 - source data 6. Unedited blots shown in Figure 1F. 533 
Figure 1 - source data 7. Uncropped blots shown in Figure 1F. 534 
Figure 1 - figure supplement 1 - source data 1. Unedited blots shown in Figure 1 - figure 535 
supplement 1. 536 
Figure 1 - figure supplement 1 - source data 2. Uncropped blots shown in Figure 1 - figure 537 
supplement 1. 538 
Figure 1 - figure supplement 2 - source data 1. Unedited blots shown in Figure 1 - figure 539 
supplement 2. 540 
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Figure 1 - figure supplement 2 - source data 2. Uncropped blots shown in Figure 1 - figure 541 
supplement 2. 542 
 543 
 544 
Figure 2. Expression of T6B reversibly blocks miRISC assembly and inhibits miRNA function 545 
in vivo. (A) Schematic of the targeting strategy to generate the T6B mouse. The construct 546 
contains a flippase recognition target site (frt) that allows homing into the Col1a1 locus when 547 
electroporated together with a vector expressing the Flippase recombinase into KH2 (Col1a1-548 
frt/Rosa26-rtTA) murine embryonic stem cells. KH2 also express the rtTA trans-activator driven 549 
by the endogenous Rosa26 (R26) promoter. (B) Immunofluorescence imaging performed 550 
using an anti-YFP antibody, showing T6B expression in a panel of tissues of adult R26T6B mice 551 
fed doxycycline for 7 days. Tissues from R26CTL (carrying the rtTA allele but not the T6B allele) 552 
were used as negative controls. (C) Protein lysates from the liver of R26T6B mice on or off 553 
doxycycline-containing chow for the indicated number of days were resolved by SDS-PAGE 554 
and Western blotting was performed with anti-HA antibody to detect expression of the T6B 555 
transgene. (D) Co-IP experiments using an anti-YFP antibody showing interaction between 556 
AGO and T6B in total liver extracts from T6B mice on doxycycline containing chow. (E) SEC 557 
elution profile of AGO2-containing complexes in liver lysates from T6B mice euthanized at the 558 
indicated time points after doxycycline administration. Notice the shift of AGO2 from the high 559 
molecular weight fractions to the low molecular weight fractions after 5 days of doxycycline 560 
treatment and the reconstitution of the full miRISC after removal of doxycycline from the diet. 561 
(F-G) Total RNA extracted from the large intestine (F) and the liver (G) of R26CTL and R26T6B 562 
mice was subjected to RNAseq (n = 3 for each strain). Left panel: scatter plot showing the 563 
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effect of T6B expression on targets of all miRNA families were generated as described in 564 
Figure 1D. The abundance of each miRNA family was calculated using dataset from Isakova et 565 
al. (Isakova et al.). Right panel: Representative cumulative distribution plot of log2 fold 566 
changes in expression of predicted targets of the indicated miRNA families.  567 
The following figure supplements and source data are available for Figure 2: 568 
Figure 2 - figure supplement 1. Epifluorescence imaging showing T6B expression in selected 569 
ESC clones. 570 
Figure 2 - figure supplement 2. IF imaging showing T6B expression in selected adult tissues. 571 
Figure 2 - figure supplement 3. Co-IP of T6B and AGO2 in colon extracts. 572 
Figure 2 - figure supplement 4. Size exclusion chromatography on extracts of T6B-expressing 573 
liver and colon. 574 
Figure 2 - source data 1. RNAseq, differential gene expression, colon and liver. 575 
Figure 2 - source data 2. Z-Scores and miRNA families abundance, colon and liver. 576 
Figure 2 - source data 3. Unedited blots shown in Figure 2C. 577 
Figure 2 - source data 4. Uncropped blots shown in Figure 2C. 578 
Figure 2 - source data 5. Unedited blots shown in Figure 2D. 579 
Figure 2 - source data 6. Uncropped blots shown in Figure 2D. 580 
Figure 2 - source data 7. Unedited blots shown in Figure 2E. 581 
Figure 2 - source data 8. Uncropped blots shown in Figure 2E. 582 
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Figure 2 - figure supplement 1 - source data 1. Unedited blots shown in Figure 2 - figure 583 
supplement 1.  584 
Figure 2 - figure supplement 1 - source data 2. Uncropped blots shown in Figure 2 - figure 585 
supplement 1.  586 
Figure 2 - figure supplement 3 - source data 1. Unedited blots shown in Figure 2 - figure 587 
supplement 3. 588 
Figure 2 - figure supplement 3 - source data 2. Uncropped blots shown in Figure 2 - figure 589 
supplement 3. 590 
Figure 2- figure supplement 4 - source data 1. Unedited blots shown in Figure 2 - figure 591 
supplement 4. 592 
Figure 2- figure supplement 4 - source data 2. Uncropped blots shown in Figure 2 - figure 593 
supplement 4.  594 
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 595 
Figure 3. Phenotypic analysis of R26T6B mice during homeostasis. (A) Rosa26+/+; Col1a1T6B/T6B 596 
females were crossed with Rosa26rtTA/+; Col1a1T6B/T6B males and doxycycline was 597 
administered by chow starting at 0.5 d.p.c. No viable pups positive for both the rtTA and T6B 598 
allele were observed (n = 15, p-value = 0.002, Fisher exact test). (B) Pregnant females were 599 
kept on doxycycline diet from E13.5 to E18.5 and the pups delivered on E18.5 by c-section. 600 
Note the significantly smaller size of Rosa26rtTA/rtTA; Col1a1T6B/T6B embryos relative to 601 
Rosa26rtTA/rtTA ;Col1a1+/+ control littermates.  Lower row: YFP detection by epifluorescence in 602 
E18.5 pups of the indicated genotypes. (C) Comparison of intestine architecture in H&E 603 
sections from R26T6B and R26CTL mice (n = 3 for each genotype) maintained on doxycycline for 604 
2 months. (D) Immunofluorescence imaging of the small intestine of R26T6B and R26CTL mice 605 
(n = 3-5 for each genotype) kept on doxycycline diet for a month (upper row), showing a 606 
reduction in lysozyme expression in Paneth cells in the crypts. Lysozyme expression in R26T6B 607 
mice returned to normal levels upon removal of doxycycline from the diet (lower row). (E) 608 
Peripheral blood analysis conducted in R26T6B and R26CTL mice (R26CTL n = 4; R26T6B n = 5). 609 
(F)  Flow cytometric analysis of bone marrow of R26T6B and R26CTL mice kept on doxycycline 610 
diet for 3 weeks showing developmental block at the Pro-B to Pre-B. p values (from left to 611 
right): *p = 0.0348, **p = 0.0023, *p = 0.0340, **p = 0.0004, unpaired t-test. R26CTL n = 4; 612 
R26T6B n = 5. (G) Flow cytometry analysis of the bone marrow of control and R26T6B mice kept 613 
on doxycycline diet for 3 weeks. p values (from left to right): p = 0.0994, **p = 0.0092, **p = 614 
0.0085, *p = 0.0312, unpaired t-test. R26CTL n = 4; R26T6B n = 5. 615 
The following figure supplements are available for figure 3: 616 
Figure 3 - figure supplement 1. Body weight and morphology of T6B-expressing embryos. 617 
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Figure 3 - figure supplement 2. IF imaging showing T6B expression in small and large intestine 618 
of R26T6B mice. 619 
Figure 3 - figure supplement 3. Ki67 expression in colon and small intestine of R26T6B and 620 
R26CTL mice. 621 
Figure 3 - figure supplement 4. Detection of goblet cells in R26T6B and R26CTL. 622 
Figure 3 - figure supplement 5. Comparison of body weight of R26T6B and R26CTL mice. 623 
Figure 3 - figure supplement 6 - Summary of complete blood count in R26T6B and R26CTL mice. 624 
Figure 3 - figure supplement 7. Flow cytometry plots related to Figure 3f.  625 
Figure 3 - figure supplement 8. Flow cytometry plots related to Figure 3g. 626 
 627 
Figure 4. T6B-induced block of miRISC assembly leads to impaired intestinal regeneration. 628 
(A) R26T6B and R26CTL mice (n = 6 for each genotype) kept on doxycycline diet were treated 629 
with Dextran Sodium Sulphate (DSS) for 5 days to induce inflammatory colitis and their weight 630 
was monitored daily. Data are presented as mean ± s.d. p values (from left to right): *p = 631 
0.034, *p = 0.005, *p = 0.029, *p = 0.024, *p = 0.011, from unpaired t test. (B) Kaplan-Meier 632 
curves of animals treated with DSS as described in panel (A). p value from log-rank test (C) 633 
Representative hematoxylin-eosin-stained sections of intestine of R26T6B and R26CTL mice (n = 634 
3 for each genotype) at different time points pre- and post-DSS treatment. (D) Ki67 635 
immunostaining of section of intestine at the indicated time points. (E) Sections from the large 636 
intestine of control and T6B mice euthanized at day 13 were subjected to RNA in situ 637 
hybridization with a probe against the IGFBP5 transcript. The results show increased levels of 638 
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IGFBP5 mRNA in ulcerated areas of R26T6B as compared to controls (n = 4 for each 639 
genotype). 640 
The following figure supplements are available for Figure 4: 641 
Figure 4 - figure supplement 1. Extent of DSS-induced injury in the colon of R26T6B and R26CTL 642 
mice. 643 
Figure 4 - figure supplement 2. Evidence of residual dysplasia in colon of R26CTL mice post-644 
DSS treatment. 645 
  646 
 32
 647 
Figure 5. T6B-induced block of miRISC assembly impairs the regeneration of the 648 
hematopoietic system. (A) Long term HSC in the bone marrow of R26T6B and R26CTL mice 649 
treated with 5-FU or subjected to repeated bleeding (n = 5 for each genotype). Mice were 650 
maintained on doxycycline containing diet throughout the experiment. (B) Kaplan-Meier plots 651 
of R26T6B (n = 5) and R26CTL (n = 5) mice treated weekly with 5-FU for seven weeks. (C) 652 
Schematic of the bone marrow transplantation experiments: T6B was induced at different time 653 
points post-transplantation, and multilineage reconstitution was assessed at the indicated time 654 
points by FACS. (D) FACS analysis conducted on the peripheral blood of irradiated recipients 655 
transplanted 1:1 with T6B-expressing and wild-type bone marrow, and maintained on 656 
doxycycline diet according to scheme shown in panel C. Data are presented as mean ± s.d. *p 657 
< 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA. off > off, n = 9; off > on, n = 10; on > off, n = 658 
8; on >on, n = 8. (E) FACS analysis showing the frequency of T6B-extressing HSCs in the 659 
bone marrow of transplanted recipient mice kept on doxycycline diet according to scheme 660 
shown in panel c. off > off, n = 5; off > on, n = 5; on > off, n = 4; on > on, n = 5, one-way 661 
ANOVA.  662 
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 663 
Figure 6. The miRNA pathway is essential in heart and skeletal muscle during homeostasis. 664 
(A) Detection of T6B expression with an anti-YFP antibody in the heart and skeletal muscle of 665 
R26T6B, CAGT6B, and R26CTL mice maintained on doxycycline containing diet for 7 days. (B) 666 
Total RNA extracted from the heart (upper panel) and the skeletal muscle (lower panel) of 667 
CAGCTL and CAGT6B mice (n = 3 for each strain) maintained on dox for 7 days was analyzed 668 
by RNAseq. Left panels: Scatter plot showing the effect of T6B expression on targets of 669 
conserved miRNA families were generated as described in figure 1D. The abundance of each 670 
miRNA family was calculated using dataset from Isakova et al. (Isakova et al.). Right panels: 671 
Representative cumulative distribution plot of log2 fold changes in expression of predicted 672 
targets of the indicated miRNA families. (C) Kaplan-Meier curves of CAGT6B and CAGCTL mice 673 
(n = 8 for each genotype) maintained on doxycycline throughout the duration of the 674 
experiment. p value from log-rank test. (D) Upper row: representative H&E staining showing 675 
marked dilation of the four cardiac chambers in hearts of CAGT6B mice compared to controls (n 676 
= 9 for each genotype). Despite having thinner walls, the histomorphology of ventricular 677 
cardiomyofibers were within normal limits. Bottom row: representative H&E staining showing 678 
degenerative and regenerative changes in the skeletal muscle of the hind limbs of CAGT6B 679 
mice compared to controls (n = 9 for each genotype). 680 
The following figure supplements and source data are available for Figure 6: 681 
Figure 6 - figure supplement 1. Comparison of body weight of CAGT6B and CAGCTL mice. 682 
Figure 6 - figure supplement 2. H&E staining showing vasculitis of pulmonary veins in CAGT6B 683 
mice. 684 
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Figure 6 – figure supplement 3. Effects of T6B expression in P. lividus and Danio rerio 685 
Figure 6 – source data 1. RNAseq, heart and muscle. 686 
Figure 6 – source data 2. Z-scores and miRNA family abundance, heart and muscle.687 
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Materials and Methods 688 
Key resource table 689 
Reagent type (species) 
or resource 




strain, strain background  
(M. musculus) 
T6B This paper 
 
Stock #036470 The T6Bwt allele is 
integrated in the 
Col1a1 locus 
strain, strain background  
(M. musculus) 






strain, strain background  
(M. musculus) 
C57BL/6J Jackson lab RRID:IMSR_JA
X:000664 
 
strain, strain background  
(M. musculus) 
Rosa26-CAGs-rtTA3 Jackson lab RRID:IMSR_JA
X:029627 
The CAG promoter 
drives the 
expression of rtTA3 










transfected construct  
(M. musculus) 
Silencer GAPDH siRNA Thermo Fisher #AM4624  
transfected construct  
(M. musculus) 
Negative Control 1 siRNA Thermo Fisher #AM4611 Nontargeting control 
antibody anti-E-Cadherin 
(Mouse monoclonal) 
BD #610181 IF: (1:750) 
antibody Anti-Lysozyme 
(Rabbit polyclonal) 
Thermo Fisher #RB-372-A1 IF: (1:200) 
antibody anti-PH3 
(Mouse monoclonal) 
Cell Signaling #970 IF: (1:200) 
antibody anti-YFP 
(Rabbit polyclonal) 
Invitrogen #A11122 IF: (1:250) 
antibody anti-Ki67 
(Rabbit monoclonal) 
Cell Signaling #12202 IF: (1:400) 
antibody anti-Rabbit IgG, Alexa 
Fluor 488 
ThermoFisher #A11034 IF: (1:250) 
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(Goat polyclonal) 
antibody anti-Mouse IgG2a, Alexa 
Fluor 594  
(Goat polyclonal) 
ThermoFisher # A-21135 IF: (1:250)  
antibody Anti-GFP 
(Chicken polyclonal) 
Abcam #ab13970 IF : (1:250) 
antibody Rat IgG 
(Rat Polyclonal) 
Sigma #I-8015 IF: (1:250) 
antibody anti-GW182  
(Rabbit polyclonal) 




Cell Signaling #2897 WB: (1:1000) 
antibody anti-RPL26 
(Rabbit polyclonal) 
Bethyl  #A300-686A WB: (1:1000) 
antibody anti-GAPDH 
(Mouse monoclonal) 
Sigma  #G8795 WB: (1:2000) 
antibody anti-βActin 
(Mouse monoclonal) 
Sigma  #A2228 WB: (1:2000) 
antibody anti-Tubulin 
(Mouse monoclonal) 
Sigma-Aldrich #T9026 WB: (1:2000) 
antibody anti-HA  
(Rabbit monoclonal) 
Cell Signaling #C29F4 WB: (1:1000) 





#NA934 WB: (1:10000) 





#NA931 WB: (1:10000) 
antibody Anti-AGO2  
(Mouse monoclonal) 
WAKO #011-22033 IP: (1 µg/100µL) 
antibody Anti-AGO1-4 
(Mouse monoclonal) 
EMD Millipore #MABE56 IP: (1 µg/100µL) 
antibody anti-FLAG 
(Mouse monoclonal) 
Cell Signaling #8146S IP: (1 µg/100µL) 
antibody anti-HA 
(Mouse monoclonal) 
Cell Signaling #2367S IP: (1 µg/100µL) 














pgk-ATG-frt plasmid Addgene RRID:Addge
ne_20734 
 





























T6B-YFP_R This paper PCR primers GTTACTTGTACAG
CTCGTCCATG 
commercial assay or kit RNAscope 2.5 HD 
Detection Reagent, 
BROWN 
ACD #320771  
commercial assay or kit RNAScope Igfbp5 Probe ACD #425738  
commercial assay or kit Superose 6 10/300 GL Cytiva #GE17-5172-
01 
Now available as 
Increase 10/300 GL,  
Cytia # GE29-0915-
96 
commercial assay or kit Novex NuPAGE 
SDS/PAGE gel system 
Thermo Fisher #NP0321  












commercial assay or kit TruSeq Stranded mRNA 









software, algorithm STAR v2.5.3a PMID: 
23104886 
  





software, algorithm miRbase version 21 https://www.mi
rbase.org/ 
  




















Surgipath Decalcifier I Leica 
Biosystems 
#3800400 formic acid solution 





other KnockOut DMEM GIBCO #10829018  
other phosphate inhibitors Roche #049068370
01 
 
other TRIzol Reagent Thermo Fisher 1#5596026  
other DAPI stain Sigma Aldrich #62248 5 μg/ml 
other Mowiol 4–88 Calbiochem #475904100
GM 
Mounting media 
other GlutaMax GIBCO #35050061  
other A/G PLUS-Agarose beads Santa Cruz #2003  
other RIPA buffer Sigma-Aldrich # R0278  
other Lipofectamine RNAiMAX Thermo Fisher #13778100 Transfection reagent 






Animal models. The Rosa26rtTA/rtTA ; Col1a1T6B/T6B (R26T6B) mice were generated by site-691 
specific integration of the transgene coding for the FLAG-HA-T6B-YFP fusion protein within the 692 
Col1a1 locus of KH2 embryonic stem cells (Col1a1-frt/Rosa26 rtTA) (Beard et al., 2006). 693 
Briefly, the FLAG-HA-T6B-YFP (FH-T6B-YFP) DNA fragment was subcloned into the targeting 694 
vector, as described in “Vectors and molecular cloning”. A mixture of 5µg of the targeting 695 
vector and 2.5µg of the pCAGGS-flpE-puro (Addgene #20733), Flippase recombinase-696 
expressing vector were electroporated into KH2 cells, using 4D-Nucleofector core unit (Lonza), 697 
following manufacturer’s “Primary cells P3” protocol. Selection of targeted clones was initiated 698 
48h after electroporation, using 150µg hygromycin per mL of culture medium. 10 days later, 699 
individual hygromycin-resistant ES cell clones were analyzed by PCR to confirm correct 700 
integration of the knock-in allele. Clones carrying the correctly integrated knock-in allele were 701 
genotyped using a three-primer PCR, with the following primers: 1) 5’-702 
AATCATCCCAGGTGCACAGCATTGCGG-3’; 2) 5’-CTTTGAGGGCTCATGAACCTCCCAGG-703 
3’; 3) 5’-ATCAAGGAAACCCTGGACTACTGCG-3’. A 287pb-long PCR product indicates 704 
successful integration of the transgene into the Col1a1 locus, while a 238bp-long PCR product 705 
indicates a wild type, untargeted locus. Two independent ES clones were injected into 706 
C57BL/6J albino blastocysts and backcrossed the resulting chimeras to C57BL/6J mice to 707 
achieve germline transmission of the recombinant allele. F1 animals were then intercrossed to 708 
generate animals expressing rtTA from the Rosa26 locus under control of the Rosa26 709 
endogenous promoter, while expressing the T6B fusion protein from the Col1a1 locus under 710 
control of the tetracycline-responsive element (TRE) and the minimal CMV promoter. Animals 711 
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were genotyped as follows: to assess the presence of the transgene in the Col1a1 locus, PCR 712 
was carried out as for the genotyping of KH2 cells. To assess the presence of the rtTA 713 
transgene in the Rosa26 locus, a three-primer PCR was performed, using the following 714 
primers: 1) 5’-AAAGTCGCTCTGAGTTGTTAT-3’; 2) 5’-GCGAAGAGTTTGTCCTCAACC-3’; 3) 715 
5’-CCTCCAATTTTACACCTGTTC-3’. A 350pb-long PCR product indicates the presence of the 716 
rtTA transgene into the Rosa26 locus, while a 297bp-long PCR product indicates the presence 717 
of a wild type locus. CAGrtTA/rtTA ; Col1a1T6B/T6B (CAGT6B) mice were generated by backcrossing 718 
R26T6B mice with Rosa26-CAGs-rtTA3 mice (a gift from Scott Lowe, MSKCC). In the Rosa26-719 
CAGs-rtTA3 mice, the knock-in allele has the CAG promoter driving the expression of the 720 
third-generation reverse tetracycline-regulated transactivator gene (rtTA3), all inserted into the 721 
Gt(ROSA)26Sor locus.  In vivo doxycycline-dependent expression of the FLAG-HA-T6B-YFP 722 
transgene was achieved by feeding mice chow that contained doxycycline at the concentration 723 
of 625mg/Kg (Envigo #TD01306). Mice were maintained and euthanized in accordance with a 724 
protocol approved by the Memorial Sloan-Kettering Cancer Center Institutional Animal Care 725 
and Use Committee. The T6B transgenic strain has been deposited at the Jackson Laboratory 726 
(JAX stock #036470) 727 
 728 
Necropsy, staining and histopathology. Mice were euthanized with CO2. Following gross 729 
examination all organs were fixed in 10% neutral buffered formalin, followed by decalcification 730 
of bone in a formic acid solution (Surgipath Decalcifier I, Leica Biosystems). Tissues were then 731 
processed in ethanol and xylene and embedded in paraffin in a Leica ASP6025 tissue 732 
processor. Paraffin blocks were sectioned at 5 microns, stained with hematoxylin and eosin 733 
(H&E), and examined by a board-certified veterinary pathologist. The following tissues were 734 
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processed and examined: heart, thymus, lungs, liver, gallbladder, kidneys, pancreas, stomach, 735 
duodenum, jejunum, ileum, cecum, colon, lymph nodes (submandibular, mesenteric), salivary 736 
glands, skin (trunk and head), urinary bladder, uterus, cervix, vagina, ovaries, oviducts, 737 
adrenal glands, spleen, thyroid gland, esophagus, trachea, spinal cord, vertebrae, sternum, 738 
femur, tibia, stifle join, skeletal muscle, nerves, skull, nasal cavity, oral cavity, teeth, ears, eyes, 739 
pituitary gland, brain. To detect goblet cells in the intestine, the AB/PAS kit (ThermoFisher 740 
#87023) was used according to the manufacturer’s instructions.  741 
 742 
Immunofluorescence. For the staining of intestine sections shown in Figure 3 and Figure 3-743 
figure supplement 2, formalin-fixed, paraffin-embedded (FFPE) slides were deparaffinized and 744 
rehydrated according to a standard xylene/ethanol series.  After heat-induced epitope retrieval 745 
in sodium citrate (pH6), tissue sections were permeabilized in triton X-100, blocked, and 746 
incubated with the following 1º antibodies:  PH3 (Cell Signaling #970) at 1:200 dilution; 747 
Lysozyme (ThermoFisher #RB-372-A1) at 1:200 dilution; E-Cadherin (BD#610181) at 1:750 748 
dilution; YFP (Invitrogen #A11122) at 1:250 dilution; Ki67 (Cell Signaling #12202) at 1:400 749 
dilution. Next, cells were washed with PBS containing 0.05% Triton X, and incubated with the 750 
following 2º antibodies: Goat anti-Rabbit IgG, Alexa Fluor 488 (ThermoFisher #A11034) at 751 
1:250 dilution; Goat anti-Mouse IgG2a, Alexa Fluor 594 (ThermoFisher #A11029) at 1:250 752 
dilution. For the staining of tissue sections shown in Figure 2, Figure 4 and Figure 2-figure 753 
supplement 2, FFPE tissue sections were cut at 5 μm and heated at 58°C for 1 hr. The 754 
antibody against GFP (Abcam, ab13970, 2µg/ml) was incubated for 1 hr and detected with 755 
Leica Bond RX. Appropriate species-matched secondary antibody and Leica Bond Polymer 756 
anti-rabbit HRP were used, followed by Alexa Fluor 488 tyramide signal amplification reagent 757 
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(Life Technologies, B40953). After staining, slides were washed in PBS and incubated in 5 758 
μg/ml 4’,6-diamidino-2-phenylindole (DAPI) (Sigma Aldrich) in PBS (Sigma Aldrich) for 5 min, 759 
rinsed in PBS, and mounted in Mowiol 4–88 (Calbiochem). Slides were kept overnight at -20°C 760 
before imaging. 761 
 762 
Immunohistochemistry. For IHC, deparaffinized sections were subjected to antigen retrieval 763 
and processed with the EnVision+ HRP kit (K401111–2, DAKO, Glostrup, Denmark) according 764 
to the manufacturer’s instructions. A primary polyclonal antibody against Ki67 (Cell Signaling 765 
#12202) at 1:400 dilution was diluted in Antibody Diluent (DAKO #S0809) and incubated 766 
overnight at 4°C. Next, sections were incubated in the provided anti-rabbit HRP-labeled 767 
polymer reagent and detection was performed according to the manufacturer’s protocol. 768 
Images were acquired using an Olympus BX-UCB slide scanner. 769 
 770 
RNA in situ hybridization. 5μm sections were obtained from formalin-fixed, paraffin-771 
embedded (FFPE) colons from age/sex-matched mice. Before staining, tissue slides were 772 
deparaffinized, rehydrated and permeabilized according to standard procedures. Detection 773 
was carried out using RNAscope 2.5 HD Detection Reagent, BROWN (ACD # 320771), with a 774 
specific RNAScope Igfbp5 Probe (ACD #425738, according to the manufacturer’s instructions. 775 
 776 
Serum chemistry and hematology. For serum chemistry, blood was collected into tubes 777 
containing a serum separator, the tubes were centrifuged, and the serum was obtained for 778 
analysis. Serum chemistry was performed on a Beckman Coulter AU680 analyzer and the 779 
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concentration of the following analytes was determined: alkaline phosphatase, alanine 780 
aminotransferase, aspartate aminotransferase, creatine kinase, gamma-glutamyl 781 
transpeptidase, albumin, total protein, globulin, total bilirubin, blood urea nitrogen, creatinine, 782 
cholesterol, triglycerides, glucose, calcium, phosphorus, chloride, potassium, and sodium. 783 
Na/K ratio, albumin/globulin ratio were calculated. For hematology, blood was collected retro-784 
orbitally into EDTA microtainers. Automated analysis was performed on an IDEXX Procyte DX 785 
hematology analyzer. 786 
 787 
Dextran sulfate sodium (DSS) treatment and post DSS treatment quantitative analyses. 788 
Mice kept in doxycycline-containing chow were treated for 5 days with 4% w/v DSS (FW 789 
40.000) (Cayman Chemical #23250) dissolved in drinking water. Body mass was monitored 790 
daily. Measurements of colon length, aggregated length of ulcers, percentage of colon with 791 
ulcers, area of ulcers, the number of immune nodules and the area of immune nodules were 792 
obtained using OMERO (https://www.openmicroscopy.org/omero/). Measurements of these 793 
parameters were used to estimate the extent of damage and colitis induced by DSS treatment. 794 
All measurements were acquired from H&E-stained colon sections. Ulcer was defined as 795 
regions of colon with complete/partial loss of epithelial structure, accompanied by massive 796 
immune infiltrates. Colon length was measured by tracing the length of muscular layer of each 797 
colon. Length of ulcer was measured as the added length of each ulcerated region along the 798 
colon. Ulcer percentage was calculated as the length of ulcer/length of colon. The area of each 799 
individual ulcer was also measured and summed for each animal. Clear immune nodules are 800 
visible, showing aggregates of immune cells with high nucleus/cytoplasm ratio. Number and 801 
area of the immune nodules were summarized for each animal. 802 
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 803 
Tissue isolation and total lysates preparation. Organs extracted from 8- to 12-week-old 804 
mice, perfused with PBS, were snap-frozen in liquid nitrogen and stored at −80 °C until further 805 
processing. To prepare total extract from solid tissues, tissues were pulverized using a mortar, 806 
resuspended in 1mL of lysis buffer per cm3 of tissue, and dounce-homogenized with a tight 807 
pestle until completely homogenized. Next, extracts were cleared by centrifugation at 20,000 × 808 
g for 5 min followed by a second step of centrifugation at 20,000 × g for 5 min. To prepare total 809 
extracts from cultured cells, pelleted cells were snap frozen in liquid nitrogen and stored at −80 810 
°C until further processing. Pellets were then resuspended in lysis buffer, incubated for 10 811 
minutes on ice, and cleared by centrifugation at 20,000 × g. Two different lysis buffers were 812 
used, depending on the specific downstream application. For IP and size exclusion 813 
chromatography, lysates were prepared in SEC buffer (150 mM NaCl, 10 mM Tris-HCl pH 7.5, 814 
2.5 mM MgCl2, 0.01% Triton X-100). For Western blotting applications, lysates were prepared 815 
in RIPA buffer (Sigma-Aldrich # R0278). Upon usage, both buffers were supplemented with the 816 
addition of EDTA-free complete protease inhibitors (Sigma-Aldrich #11836170001), phosphate 817 
inhibitors (Roche #04906837001), and 1mM DTT. 818 
 819 
Cell Lines and Culture Conditions. Cell lines were maintained in log-phase growth in a 820 
humidified incubator at 37°C, 5% CO2 prior to experimental manipulation. HCT116 colorectal 821 
adenocarcinoma cells were obtained from ATCC prior this study and tested negative for 822 
Mycoplasma and were maintained in McCoy’s medium supplemented with 10% heat-823 
inactivated fetal calf serum (FCS, GIBCO, Cat#16141079), 10 U/ml penicillin/streptomycin, and 824 
2 mM L-glutamine. Mouse embryonic fibroblasts (MEF) were grown in Dulbecco’s Modified 825 
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Eagle Medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS, 826 
GIBCO), 10 U/ml penicillin/streptomycin, and 2 mM L-glutamine. KH2 embryonic stem cells 827 
were cultured in gelatin-coated plates in presence of irradiated DR4 Mouse Embryonic 828 
Fibroblasts (ThermoFisher #A34966), and maintained in KnockOut DMEM (GIBCO, 829 
Cat#10829018), supplemented with 15% FCS (GIBCO), GlutaMax (GIBCO Cat#35050061), 830 
100 µM non-essential amino acids (Sigma-Aldrich Cat#M7145), 1000 U/mL leukemia inhibitory 831 
factor (LIF, Millipore Cat#ESG1107), 10U/mL penicillin/streptomycin (GIBCO Cat#15070063) 832 
and 100 mM 2-Mercaptoethanol (Bio-Rad Cat#1610710), and nucleosides (Millipore Cat#ES-833 
008-D). 834 
 835 
Flow cytometry. Analysis of bone marrow populations was performed by harvesting femurs 836 
and tibiae from euthanized mice. Bone marrow was isolated by centrifugation, resuspended in 837 
FACS buffer (PBS with 2% fetal calf serum) and passed through a 40µm cell strainer to make 838 
a single cell suspension. Nonspecific antibody binding was blocked by incubation with 10µg/ml 839 
Rat IgG (Sigma #I-8015) for 15 min on ice. Antibodies used to identify HSCs included a 840 
cocktail of biotinylated lineage antibodies (Gr1, CD11b, TER119, B220, CD3, CD4, CD8), 841 
CD117 (c-kit) APC (2B8), Sca-1 (D7) PE-cy7, CD150 PE, and CD48 Pacific Blue. B cell 842 
progenitors were identified with the following antibodies: B220, CD19, CD25, CD43, IgM, IgD 843 
and c-kit. For analysis of peripheral blood mononuclear cells, blood was collected retro-844 
orbitally from live mice into EDTA microtainers. Whole blood was lysed in ACK buffer for 5 min 845 
at room temperature, washed with FACS buffer and pelleted prior to antibody staining. Mature 846 
blood populations were identified with the following antibodies: CD45.1, CD45.2, Gr1, CD11b, 847 
B220, CD3. Cells were incubated with primary antibodies for 45 min, washed once with FACS 848 
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buffer and incubated with BV711 streptavidin conjugate for 15 min. All incubations were carried 849 
out on ice and protected from light. Antibodies were purchased from Biolegend or eBioscience. 850 
 851 
Bone marrow transplantation. 8–12-week-old CD45.1+ C57BL/6 (BoyJ) mice (JAX) were 852 
lethally irradiated by exposure to 1100cGy of gamma irradiation from a cesium source, 853 
administered in two doses, split 4h apart. Bone marrow suspensions from CAGT6B (CD45.2+) 854 
and BoyJ mice were counted, mixed 1:1 and transferred intravenously by retro-orbital injection 855 
into isofluorane-anesthetized, irradiated recipients. 856 
 857 
Size exclusion chromatography (SEC). SEC was performed using a Superose 6 10/300 GL 858 
prepacked column (GE Healthcare) equilibrated with SEC buffer essentially as previously 859 
described (La Rocca et al., 2015; Olejniczak et al., 2013). Briefly: 400μL (1.5–2 mg) of total 860 
extracts precleared by centrifugation were run on the SEC column at a flow rate of 0.3 mL/min. 861 
1mL fractions were collected. Proteins were extracted from each fraction by TCA precipitation 862 
following standard procedures, and run on SDS-PAGE gels for Western blotting analysis. 863 
 864 
Western blotting and antibodies. Western blotting was performed using the Novex NuPAGE 865 
SDS/PAGE gel system (Invitrogen). Total cell lysates were run either on 3–8% Tris-acetate or 866 
4–12% Bis-Tris precast gels, transferred to nitrocellulose membranes, and probed with 867 
antibodies specific to proteins of interest. Detection and quantification of blots were performed 868 
on Amersham hyperfilm ECL (Cytiva #28906839) and developed on film processor SRX-101A 869 
(Konica).  Antibodies used for Western blots were obtained from commercial sources as 870 
 47
follows: anti-GW182 (Bethyl #A302-239A), anti-Ago2 (Cell Signaling #2897), anti-PABP1 (Cell 871 
Signaling #4992), anti-RPL26 (Bethyl #A300-686A), anti-GAPDH (Sigma #G8795), anti-βActin 872 
(Sigma #A2228) anti-GFP (Roche #11814460001), anti-Tubulin (Sigma-Aldrich #T9026) anti-873 
HA (Cell Signaling #C29F4), anti-Rabbit IgG, HRP-conjugated (GE Healthcare #NA934), anti-874 
Mouse IgG, HRP-conjugated (GE Healthcare #NA931).  875 
 876 
Immunoprecipitation (IP). For IP of AGO-T6B complexes from human HCT116 cells, 500μg 877 
of lysates in 500 μL of SEC buffer were incubated for 3 hours with primary antibodies directed 878 
to either AGO proteins (WAKO anti-AGO2 #011-22033, EMD Millipore anti-panAGO 879 
#MABE56) or directed to T6B-fusion protein (Cell Signaling anti-FLAG #8146S, Cell Signaling 880 
anti-HA #2367S) or mouse IgG1 isotype control (Cell Signaling #5415). Next, lysates were 881 
incubated with 20µl of protein A/G PLUS-Agarose beads (Santa Cruz #2003) for 1 hour. For IP 882 
of AGO-T6B complexes from mouse tissues, 500μg of lysates in 500 μL of SEC buffer were 883 
incubated for 2 hours with GFP-trap magnetic agarose beads (Chromotek #gtma-10) or 884 
binding control beads (Chromotek #bmab-20). The immune complexes were run on SDS-885 
PAGE and analyzed by Western blotting. 886 
 887 
Vectors and molecular cloning. The targeting vector expressing the FH-T6B-YFP under 888 
control of TRE and CMV minimal promoter, was generated from a modified version of the pgk-889 
ATG-frt plasmid (Addgene plasmid #20734), in which the region of pgk-ATG-frt comprised 890 
between the EcoRI site and the PciI site was substituted with the rabbit β-globin 891 
polyadenylation signal (RBG pA). The FH-T6B-YFP DNA insert was generated by PCR using 892 
the plasmid pIRES-Neo-FH-T6B-YFP58 as a template. PCR was carried out using the following 893 
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primers: Forward: 5’-GACTACAAGGACGACGATGACAAG-3’, Reverse: 894 
GTTACTTGTACAGCTCGTCCATG. Next, the modified pgk-ATG-frt, was cut with NcoI, filled-in 895 
to produce blunt ends, dephosphorylated and ligated to the PCR-generated FH-T6B-YFP DNA 896 





To generated cell lines expressing either FH-T6B-YFP or FH-T6BMut-YFP fusion proteins in a 902 
doxycycline-inducible manner, a modified version of the retroviral vector pSIN-TREtight-HA-903 
UbiC-rtTA3-IRES-Hygro (hereafter TURN vector, a gift from Scott Lowe) was used to 904 
transduce commercially available HCT116 and MEFs cell lines. TURN is an all-in-one Tet-on 905 
vector that includes: 1) The rtTA3 gene under the human ubiquitin C promoter; 2) The 906 
transgene of interest driven by a tetracycline-responsive element (TRE)/CMV promoter. We 907 
used the pIRES-Neo-FH-T6B-YFP described in Hauptmann ae al.58 as a template to generate 908 
by PCR the DNA fragments coding either for FH-T6B-YFP or for FH-T6BMut-YFP fusion 909 
proteins. DNA fragments were then inserted into the XhoI/EcoRI-digested TURN vector to 910 




Small RNA Transfection. Silencer GAPDH siRNA (ThermoFisher AM4624) and Silencer 914 
Select Negative Control 1 siRNA (ThermoFisher AM4611). Small RNAs were transfected at 10 915 
pM per 1 × 106 cells. MEFs were reverse transfected using Lipofectamine RNAiMAX. 916 
Lipofectamine RNAiMAX was combined with 20 µM small RNAs at a 4:3 ratio (vol:vol) in Opti-917 
MEM and incubated for 20 min at room temperature. Trypsinized cells were added to culture 918 
dishes containing siRNAs and Lipofectamine RNAiMAX at 3.8 × 104 cells per centimeter 919 
squared. Three volumes of complete medium were added to culture dishes and cells were 920 
incubated for 2–3 days before further processing. 921 
 922 
Small RNA sequencing. Total RNA was extracted from MEFs transduced with the retroviral 923 
vectors encoding a doxycycline inducible T6B or T6Bmut transgene and cultured in the 924 
presence or absence of doxycycline. Small RNA-seq library preparation was as described in 925 
(Hafner et al., 2011). Briefly, 1 µg total RNA was ligated to nine distinct pre-adenylated 26-nt 926 
3’-adapters with a 5-nt barcode using a mutated and truncated Rnl2 followed by urea gel 927 
purification and size selection and 5’-adapter ligation with Rnl1. This ligation reaction was 928 
again gel purified and size-selected for fully ligated product and reverse transcribed using 929 
SuperScript III RT followed by PCR amplification using Taq polymerase for 25 cycles. The final 930 
PCR product was separated on a 2% agarose gel in TBE buffer and extracted using the 931 
QIAgen gel extraction kit according to the manufacturer's instructions including all optional 932 
steps. After high-throughput sequencing, small RNA reads were aligned to a miRNA genome 933 
index built from 1,915 murine pre-miRNA sequences from miRbase version 21(Kozomara et 934 
al., 2019)(ftp://mirbase.org/pub/mirbase/21/) using Bowtie v2.4.296. Mature miRNA abundance 935 
was calculated by counting reads falling within 4 bps at each of the 5’ and 3’ end of the 936 
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annotated mature miRNAs. miRNA seed family data were downloaded from the TargetScan 937 
website at 938 
http://www.targetscan.org/mmu_71/mmu_71_data_download/miR_Family_Info.txt.zip. For 939 
miRNA family level analysis, read counts mapping to members of the same miRNA family 940 
were summed up. 941 
 942 
RNAseq analysis. Total RNA from heart, skeletal muscle, colon and liver of sex-matched 943 
littermate animals, and total RNA from cell lines was extracted using TRIzol Reagent 944 
(Invitrogen) according to manufacturer’s instructions and subjected to DNase (QIAGEN) 945 
treatment. After RiboGreen quantification and quality control by Agilent BioAnalyzer, 500ng of 946 
total RNA with RIN values of 7.0-10 underwent polyA selection and TruSeq library preparation 947 
according to instructions provided by Illumina (TruSeq Stranded mRNA LT Kit, catalog # RS-948 
122-2102), with 8 cycles of PCR. Samples were barcoded and run on a HiSeq 4000 in a 949 
PE50/50 run, using the HiSeq 3000/4000 SBS Kit (Illumina).  An average of 34 million paired 950 
reads was generated per sample. The percent of mRNA bases averaged 60% over all 951 
samples. Reads were aligned to the standard mouse genome (mm10) using STAR 952 
v2.5.3a(Dobin et al., 2013). RNA reads aligned were counted at each gene locus. Expressed 953 
genes were subjected to differential gene expression analysis using DESeq2 (Love et al., 954 
2014), log2Fold changes were determined comparing T6B expressing tissues to controls. 955 
 956 
Z-score calculation. For each conserved miRNA families the mean log2-fold change of 957 
predicted targets, as defined by Targetscan, compared to the rest of the transcriptome (back-958 
ground) was calculated. The means were converted to z-scores as described by Kim and 959 
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Volsky (Kim and Volsky, 2005):  Z-score = (Sm - µ)*m1/2*∂-1 , where Sm is the mean of log2-960 
fold changes of genes for a given gene set, m is the size of the gene set and µ and ∂ are the 961 
mean and the standard deviation of background log2-fold change values. 962 
 963 
Real-time quantitative PCR. Real-time quantitative PCR analysis to assess the expression 964 
levels of the territorial marker genes involved in the developmental gene regulatory network of 965 
the sea urchin where conducted as previously described by Cavalieri et al. (Cavalieri et al., 966 
2009). Briefly, total RNA from batches of 150 microinjected embryos was extracted by using 967 
the High Pure RNA Isolation kit (Roche). RNA samples were treated with reagents provided by 968 
the Turbo DNA-free kit (Ambion) and resuspended in a final volume of 30 µl. Reverse 969 
transcription into cDNA was performed in an 80 µl reaction using random hexamers and the 970 
TaqMan Reverse Transcription Reagents kit (Applied Biosystems). The resulting cDNA sample 971 
was further diluted and the equivalent amount corresponding to one embryo was used as 972 
template for Q-PCR analysis. Q-PCR experiments were performed from two different batches 973 
and all reactions were run in triplicate on the 7300 Real-Time PCR system (Applied 974 
Biosystems) using SYBR Green detection chemistry (Applied Biosystems). ROX was used as 975 
a measure of background fluorescence and MBF-1 and z12 mRNAs were used as internal 976 
controls. At the end of the amplification reactions, a ‘melting-curve analysis’ was run to confirm 977 
the homogeneity of all Q-PCR products. Calculations from Q-PCR raw data were performed by 978 
the RQ Study software version 1.2.3 (Applied Biosystems), using the comparative Ct method 979 
(Ct). Oligonucleotide primer pairs used for qPCR reactions and amplicon lengths have been 980 
described previously (Cavalieri et al., 2008) (Cavalieri et al., 2011) (Cavalieri and Spinelli, 981 
2014) (Cavalieri et al., 2017) (Turturici et al., 2018). 982 
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Figure Supplement Legends 1254 
 1255 
Figure 1- figure supplement 1. (a) HCTT116 cells transduced with retroviral vectors expressing a 1256 
doxycycline-inducible T6B or T6BMut transgene (FH-T6B-YFP) were cultured in the presence of 1257 
doxycycline for 48h. Whole cells lysates were probed with an anti-HA antibody. (b) Lysates from (a) 1258 
were immunoprecipitated with the indicated antibodies and blotted against AGO2, FH-T6B-YFP (anti-1259 
HA) and GAPDH. Note that the T6B fusion protein, but not its mutant version (T6BMut), binds to AGO 1260 
proteins. Lower panel. Aminoacid sequence of the T6B and T6BMut fusion proteins. Both T6B versions 1261 
have HA and FLAG tags at the N termini and are fused to the yellow fluorescent protein (YFP) at the C-1262 
termini. In T6BMut, all Tryptophan residues (red) are mutated to Alanine to prevent interaction with AGO 1263 
proteins. Blue, FLAG-tag; light blue, HA-tag; bold black, T6B; green, YFP. 1264 
 1265 
Figure 1- figure supplement 2. Size exclusion chromatography was performed on whole cell lysates 1266 
from MEFs transduced with retroviral vectors expressing a doxycycline-inducible T6B or T6BMut 1267 
transgene and cultured in presence of doxycycline for 48h. Eluted fractions were probed with the anti-1268 
AGO2 or anti-HA antibodies to determine the elution profile of AGO2 and T6B, respectively.  1269 
 1270 
Figure 2 - figure supplement 1 (a) Two independent targeted ES clones were cultured in the 1271 
presence or absence of doxycycline for 48h and examined by epifluorescence microscopy to detect 1272 
FH-T6B-YFP expression. The same exposure was used for all images. Bright field images are also 1273 
shown for each clone. (b) Whole cell lysates from the clones shown in (a) were probed with an anti-HA 1274 
antibody to detect expression of the T6B fusion protein.  1275 
 1276 
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Figure 2 - figure supplement 2. Immunofluorescence imaging using a YFP-specific antibody, showing 1277 
T6B expression in a panel of tissues of adult R26T6B mice (second column) and CAGT6B mice (third 1278 
column) fed doxycycline-containing diet for 7 days. Tissues from R26CTL (first column) mice fed 1279 
doxycycline-containing diet for 7 days were included as negative controls. 1280 
 1281 
Figure 2 - figure supplement 3. Total extracts from the colon of R26T6B mice kept on doxycycline-1282 
containing diet for 1 week were immunoprecipitated using an anti-YFP antibody and probed with the 1283 
indicated antibodies to measure the interaction between the T6B fusion protein and AGO2 in vivo. An 1284 
anti-HA antibody was used to detect T6B. 1285 
 1286 
Figure 2 - figure supplement 4. SEC fractionation followed by Western blotting of total extracts from 1287 
the liver and large intestine of control and R26T6B mice treated with doxycycline-containing chow for 7 1288 
days. The shift of AGO2 from high molecular weight to low molecular weight complexes confirms 1289 
disruption of the miRISC. 1290 
 1291 
Figure 3 - figure supplement 1. (a) Litter obtained by c-section from a pregnant Rosa26rtTA/rtTA; 1292 
Col1a1T6B/+ female crossed to a Rosa26rtTA/rtTA; Col1a1T6B/+  male and maintained on doxycycline from 1293 
d.p.c. 13.5 to d.p.c. 18.5. (b) Pups from (a) were weighted and genotyped and the results plotted. p-1294 
value: two-tailed unpaired t test. 1295 
 1296 
Figure 3 - figure supplement 2. Immunofluorescence imaging of the small and large intestine of 1297 
R26T6B and R26CTL mice kept on doxycycline diet for a month. An antibody against YFP was used to 1298 
detect the T6B fusion protein.  1299 
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 1300 
Figure 3 - figure supplement 3. Sections from the colon and small intestine sections of R26T6B and 1301 
control mice kept on doxycycline-containing diet for 2 months were probed by IHC with an anti-Ki67 1302 
antibody.  1303 
 1304 
Figure 3 - figure supplement 4. Detection of goblet cells by staining of acidic and neutral mucins in 1305 
intestine sections from R26T6B and control mice kept on doxycycline diet for 2 months. Neutral mucins 1306 
are stained with periodic acid-Shiff whereas acidic mucins are stained with Alcian blue. 1307 
 1308 
Figure 3 - figure supplement 5. Body weight of R26T6B (n = 5) and control (n = 8) female mice was 1309 
assessed after 2 month-administration of doxycycline-containing chow. ns, not significant (p = 0. 6264, 1310 
unpaired t test). 1311 
 1312 
Figure 3 - figure supplement 6. Complete blood counts (CBC) of whole blood from R26T6B and R26CTL 1313 
mice taken after 3 weeks on doxycycline. Abbreviations are as follows: RBC = red blood cell count, 1314 
HGB = hemoglobin, HCT = hematocrit, MCV = mean corpuscular volume, MCH = mean cell 1315 
hemoglobin, RDW = red cell distribution width, RET = reticulocyte count, WBC = white blood cell count, 1316 
PLT = platelet count. 1317 
 1318 
Figure 3 - figure supplement 7. Representative flow cytometry plots showing the gating strategy for 1319 
the identification of hematopoietic stem and progenitor cells from whole bone marrow harvested from 1320 
R26T6B and R26CTL mice maintained on doxycycline diet for 3 weeks. LT-HSC: Lin- Kit+ Sca1+ CD150+ 1321 
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CD48-, ST-HSC: Lin- Kit+ Sca1+ CD150- CD48-, MPP2: Lin- Kit+ Sca1+ CD150+ CD48+, MPP3/4: 1322 
Lin- Kit+ Sca1+ CD150- CD48+. 1323 
 1324 
Figure 3 - figure supplement 8. Representative flow cytometry plots showing the gating strategy for 1325 
the identification of B cell lineage populations from whole bone marrow harvested from R26T6B and 1326 
R26CTL mice maintained on doxycycline diet for 3 weeks. Pro-B: B220+CD19+IgD-IgM-CD25-Kit+, Pre-1327 
B: B220+CD19+IgD-IgM-CD25+, Imm B: B220+CD19+IgD-IgM+, Mat B: B220+CD19+IgD+IgM+/lo. 1328 
 1329 
Figure 4 - figure supplement 1. Bar plots showing measurement of colon length, aggregated length of 1330 
ulcers, percentage of colon with ulcers, area of ulcers, number of immune nodules and the area of 1331 
immune nodules performed on H&E longitudinal sections of colon from R26CTL and R26T6B mice 5 days 1332 
post-DSS treatment. Measurements of these parameters were obtained using OMERO 1333 
(https://www.openmicroscopy.org/omero/) and used to estimate the extent of damage and colitis 1334 
induced by DSS treatment. Plots show that no significant differences between R26CTL and R26T6B mice 1335 
were observed, suggesting that both groups experienced similar level of DSS-induced colitis. 1336 
 1337 
Figure 4 - figure supplement 2.  Representative immunohistochemistry image showing Ki67 signal in 1338 
control mice (n = 3) 5 days after DSS treatment was discontinued. The presence of highly proliferating 1339 
cells indicates residual dysplasia. 1340 
 1341 
Figure 6 - figure supplement 1. Body weight of CAGT6B and control mice maintained on doxycycline 1342 
for up to 45 days was assessed the day on which euthanasia was performed. n = 8 (4 females and 4 1343 
males) for each genotype (age and sex matched). Mice were kept on doxycycline diet throughout the 1344 
duration of the experiment and control mice were euthanized at day 45. P-values: unpaired t-test. 1345 
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 1346 
Figure 6 - figure supplement 2. Representative H&E staining showing vasculitis of the pulmonary 1347 
veins as revealed by inflammatory immune cell infiltration of the vessel wall (arrows).  1348 
 1349 
Figure 6 - figure supplement 3. T6B blocks miRNA activity in sea urchins and zebrafish. (a) Left 1350 
panel: Representative examples of Mediterranean sea urchin (P. lividus) zygotes injected with 1 pg of 1351 
in vitro-transcribed mRNA coding for either T6B or T6BMut proteins and observed under DIC optics at 48 1352 
hours post-fertilization. Both embryos are oriented in a vegetal view. T6B-expressing embryos 1353 
displayed severe developmental aberrations ranging from the failure to form a proper archenteron and 1354 
skeletal structures, to overall delay in development and embryonic lethality. By contrast, control T6BMut-1355 
expressing embryos observed at the same developmental stage went through embryogenesis normally 1356 
and exhibited the characteristic easel-like shape of the echinoid pluteus larva. Right panel: quantitative 1357 
PCR showing dysregulation of territorial marker genes involved in the developmental gene regulatory 1358 
network of the sea urchin (Cavalieri and Spinelli, 2015a) (Cavalieri and Spinelli, 2015b)  upon T6B 1359 
expression. Data are indicated as fold difference in transcript abundance with respect to control T6BMut-1360 
expressing embryos at the same stage of development. The gray region represents changes in mRNA 1361 
abundance corresponding to less than 3-fold difference, while error bars are standard errors for the 1362 
qPCR replicates. Abbreviations: PMCs, primary mesenchyme cells; SMCs, secondary mesenchyme 1363 
cells. (b) Zebrafish (Danio rerio) fertilized eggs were injected with 75 pg of in vitro-transcribed mRNA 1364 
coding for either T6B or T6BMut fusion proteins. While T6BMut-expressing embryos developed normally, 1365 
the majority of T6B-expressing embryos underwent severe developmental defects. 1366 
 1367 
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Figure 3. Phenotypic analysis of R26T6B mice during homeostasis. (a) R26+/+; ColA1T6B/T6B females were crossed with R26rtTA/+; ColA1T6B/T6B males 
and doxycycline was administered by chow starting at 0.5 d.p.c. No viable pups positive for both the rtTA and T6B allele were observed (n = 15, 
p-value = 0.002, Fisher exact test). (b) Pregnant females were kept on doxycycline diet from E13.5 to E18.5 and the pups delivered on E18.5 by 
c-section. Note the significantly smaller size of R26rtTA/rtTA; ColA1T6B/T6B embryos relative to R26rtTA/rtTA ;ColA1+/+ control littermates. These embryos were 
affected by generalized decreased growth that was not caused by a pathologic process associated with lesions visible on routine H&E histopathology 
(data not shown). Lower row: YFP detection by epifluorescence in E18.5 pups of the indicated genotypes. (c) Comparison of intestine architecture 
in H&E sections from R26T6B and R26CTL mice (n = 3 for each genotype) maintained on doxycycline for 2 months. (d) Immunofluorescence imaging 
of the small intestine of R26T6B and R26CTL mice (n = 3-5 for each genotype) kept on doxycycline diet for a month (upper row), showing a reduction 
in lysozyme expression in Paneth cells in the crypts. Lysozyme expression in R26T6B mice returned to normal levels upon removal of doxycycline 
from the diet (lower row). (e) Peripheral blood analysis conducted in R26T6B and R26CTL mice (R26CTL n = 4; R26T6B n = 5). (f) Flow cytometric analysis 
of bone marrow of R26T6B and R26CTL mice kept on doxycycline diet for 3 weeks showing developmental block at the Pro-B to Pre-B. p values (from 
left to right): *p = 0.0348, **p = 0.0023, *p = 0.0340, **p = 0.0004, unpaired t-test. R26CTL n = 4; R26T6B n = 5. (g) Flow cytometry analysis of the bone 

































































Figure 4. T6B-induced block of miRISC assembly leads to impaired intestinal regeneration. (a) R26T6B and R26CTL mice (n = 6 for each 
genotype) kept on doxycycline diet were treated with Dextran Sodium Sulphate (DSS) for 5 days to induce inflammatory colitis and their weight was 
monitored daily. Data are presented as mean ± s.d. p values (from left to right): *p = 0.034, *p = 0.005, *p = 0.029, *p = 0.024, *p = 0.011, from 
unpaired t test. (b) Kaplan-Meier curves of animals treated with DSS as described in panel (a). p value from log-rank test (c) Representative 
hematoxylin-eosin-stained sections of intestine of R26T6B and R26CTL mice (n = 3 for each genotype) at different time points pre- and post-DSS 
treatment. (d) Ki67 immunostaining of section of intestine at the indicated time points. (e) Sections from the large intestine of control and T6B mice 
euthanized at day 13 were subjected to RNA in situ hybridization with a probe against the Igfbp5 transcript. The results show increased levels of 
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Figure 5. T6B-induced block of miRISC assembly impairs the regeneration of the hematopoietic system. (a) Long term HSC in the bone 
marrow of R26T6B and R26CTL mice treated with 5-FU or subjected to repeated bleeding (n = 5 for each genotype). Mice were maintained on doxycy-
cline containing diet throughout the experiment. (b) Kaplan-Meier plots of R26T6B (n = 5) and R26CTL (n = 5) mice treated weekly with 5-FU for seven 
weeks. (c) Schematic of the bone marrow transplantation experiments: T6B was induced at different time points post-transplantation, and multilin-
eage reconstitution was assessed at the indicated time points by FACS. (d) FACS analysis conducted on the peripheral blood of irradiated recipients 
transplanted 1:1 with T6B-expressing and wild-type bone marrow, and maintained on doxycycline diet according to scheme shown in panel c. Data 
are presented as mean ± s.d. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA. off > off, n = 9; off > on, n = 10; on > off, n = 8; on > on, n = 8. (e) 
FACS analysis showing the frequency of T6B-extressing HSCs in the bone marrow of transplanted recipient mice kept on doxycycline diet according 
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Figure 1-figure supplement 1. (a) HCTT116 cells transduced with retroviral vectors expressing a doxycycline-inducible T6B or T6BMut transgene 
(FH-T6B-YFP) were cultured in the presence of doxycycline for 48 hours. Whole cells lysates were probed with an anti-HA antibody. (b) Lysates from 
(a) were immunoprecipitated with the indicated antibodies and blotted against Ago2, FH-T6B-YFP (anti-HA) and GAPDH. Note that the T6B fusion 
protein, but not its mutant version (T6BMut),  binds to Argonaute2. Lower panel. Aminoacid sequence of the T6B and T6BMut fusion proteins. Both T6B 
versions have HA and FLAG tags at the N termini, and are fused to the yellow fluorescent protein (YFP) at the C-termini. In T6BMut, all Tryptophan 
residues (red) are mutated to Alanine to prevent interaction with Argonaute proteins. Blue, FLAG-tag; light blue, HA-tag; bold black, T6B; green, YFP.
a b







Figure 1-figure supplement 2. T6B prevents miRISC assembly in murine cells. Size exclusion chromatography was performed on whole cell 
lysates from MEFs transduced with retroviral vectors expressing a doxycycline-inducible T6B or T6Bmut  transgene and cultured in presence of 
doxycycline for 48h. Eluted fractions were probed with the anti-Ago2 or anti-HA antibodies to determine the elution profile of AGO2 and T6B, 
respectively. 
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Figure 2-figure supplement 1

















(>2MDa)                   670kDa     440kDa     158kDa
Figure 2-figure supplement 4. SEC fractionation followed by Western blotting of total extracts from the liver and large intestine of 
control and R26T6B mice treated with doxycycline-containing chow for 7 days. The shift of AGO2 from high molecular weight to low 
molecular weight complexes confirms disruption of the miRISC.
Figure 2-figure supplement 4
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Figure 3-figure supplement 3
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Figure 3-figure supplement 5
Figure 3-figure supplement 6






































Figure 3-figure supplement 7
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Figure 6-figure supplement 1
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Figure 6-figure supplement 3
